Pactiv Evergreen Inc

Finanzen von Pactiv Evergreen Inc (PTVE)

$18.010

+0.050 (+0.28%)Zum Schluss

Umsatzquellen von PTVE

Pactiv Evergreen Inc (PTVE) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Drinkware, accounting for 24.5% of total sales, equivalent to $328.00M. Other significant revenue streams include Containers and Cartons for fresh beverage products. Understanding this composition is critical for investors evaluating how PTVE navigates market cycles within the Non-Paper Containers & Packaging industry.

Profitabilität und Margen von PTVE

Evaluating the bottom line, Pactiv Evergreen Inc maintains a gross margin of 22.04%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.59%, while the net margin is 4.08%. These profitability ratios, combined with a Return on Equity (ROE) of -11.35%, provide a clear picture of how effectively PTVE converts its operational activities into shareholder value.

PTVE im Vergleich zur Peergroup

In the context of the broader market, PTVE competes directly with industry leaders such as GEF and SEE. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, PTVE's gross margin of 22.04% stands against GEF's 23.39% and SEE's 27.40%. Such benchmarking helps identify whether Pactiv Evergreen Inc is trading at a premium or discount relative to its financial performance.

Financials

FY2024Q4
YoY:
-3.85%
1.23B
Total Revenue
FY2024Q4
YoY:
+16.39%
142.00M
Operating Profit
FY2024Q4
YoY:
+127.27%
50.00M
Net Income after Tax
FY2024Q4
YoY:
+136.36%
0.26
EPS - Diluted
FY2024Q4
YoY:
-138.46%
10.00M
Free Cash Flow
FY2024Q4
YoY:
+10.98%
22.04
Gross Profit Margin - %
FY2024Q4
3.17
FCF Margin - %
FY2024Q4
YoY:
+135.84%
4.08
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten